Hattesohl et al. demonstrated that eNose derived VOCs profiles were not different between COPD patients with and without an alpha 1-antitrypsin (AAT) deficiency, after internal cross-validation. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.